This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Save the date!
November 6–8, 2023Munich, Germany

Save the date!
November 6–8, 2023,
Munich, Germany

Spotlight on: Polpharma Biologics

About Polpharma Biologics

Polpharma Biologics provides world-class solutions for the development and manufacture of biologics in both mammalian and microbial expression systems. From cell line development to fill & finish, we provide a truly integrated CDMO platform for the cost-effective and rapid delivery of novel biologics and biosimilars at pre-clinical, clinical and commercial scale.

We are rapidly expanding biopharmaceutical company dedicated to improving patients’ lives by providing affordable, high-quality biologics.

We operate three state-of-the-art facilities across Europe, located in Utrecht, Gdańsk and Warsaw which provide solutions to all steps of the biological value chain from cell line generation through process development to biopharmaceutical cGMP manufacturing. We can offer:

  • Cell line development based on proprietary CHOBC® expression platform complemented by SPOT™ and SLIM™ technology
  • Full analytical methods and process development
  • Process optimization, scale up and characterization
  • GMP DS production out of mammalian cell culture at up to 2000 L scale
  • GMP DS production in microbial systems at up to 500 L scale
  • DP formulation development
  • F&F (vials, pre-filled syringes, lyophilization)

To serve the growing global demand for biopharmaceuticals, we have built commercial-scale GMP production facility for drug substance manufacturing 20 km from capital of Poland, Warsaw. The facility will become operational in 2021 and will have a total capacity of 10 x 2000 L cell cultures for drug substance production.

Polpharma Biologics’ is led by a team with decades of international experience and a proven track record in biologics development, clinical and commercial production, registration and commercialisation.

Our dedicated and skilled scientists and engineers provide invaluable expertise and insightful advice, and our Project Management Team ensures complete transparency, providing you with access to all the information you may require to drive your project forward on your terms.

We care about your products, your experience with us and your success.


How Is Polpharma Biologics Evolving its Business Model to Meet the Future of Healthcare?


How is Polpharma Biologics Innovating through the Integration of Advanced Cell Line Development Capabilities to Help Shape the Future of Healthcare